000 | 01408 a2200397 4500 | ||
---|---|---|---|
005 | 20250517070250.0 | ||
264 | 0 | _c20161213 | |
008 | 201612s 0 0 eng d | ||
022 | _a1476-5381 | ||
024 | 7 |
_a10.1111/bph.13404 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeo, C H | |
245 | 0 | 0 |
_aTime-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin). _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cMar 2016 |
||
300 |
_a1005-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Abdominal _xdrug effects |
650 | 0 | 4 |
_aEpoprostenol _xphysiology |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesenteric Arteries _xdrug effects |
650 | 0 | 4 |
_aMesenteric Veins _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aRecombinant Proteins _xblood |
650 | 0 | 4 |
_aRelaxin _xblood |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aVasodilation _xdrug effects |
700 | 1 | _aJelinic, M | |
700 | 1 | _aNg, H H | |
700 | 1 | _aTare, M | |
700 | 1 | _aParry, L J | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 173 _gno. 6 _gp. 1005-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13404 _zAvailable from publisher's website |
999 |
_c25535492 _d25535492 |